{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:05:44Z","timestamp":1793833544814,"version":"4.6.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To determine factors associated with outcomes following pelvic exenteration for advanced nonrectal pelvic malignancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The <jats:italic toggle=\"yes\">PelvEx Collaborative<\/jats:italic> provides large volume data from specialist centers to ascertain factors associated with improved outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Consecutive patients who underwent pelvic exenteration for nonrectal pelvic malignancy between 2006 and 2017 were identified from 22 tertiary centers. Patient demographics, neoadjuvant therapy, histopathological assessment, length of stay, 30-day major complication\/mortality rate were recorded.<\/jats:p>\n            <jats:p>The primary endpoints were factors associated with survival. The secondary endpoints included the difference in margin rates across the cohorts, impact of neoadjuvant treatment on survival, associated morbidity, and mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>One thousand two hundred ninety-three patients were identified. 40.4% (n = 523) had gynecological malignancies (endometrial, ovarian, cervical, and vaginal), 35.7% (n = 462) urological (bladder), 18.1% (n = 234) anal, and 5.7% had sarcoma (n = 74).<\/jats:p>\n            <jats:p>The median age across the cohort was 63 years (range, 23\u201385). The median 30-day mortality rate was 1.7%, with the highest rates occurring following exenteration for recurrent sarcoma or locally advanced cervical cancer (3.3% each). The median length of hospital stay was 17.5 days. 34.5% of patients experienced a major complication, with highest rate occurring in those having salvage surgery for anal cancer.<\/jats:p>\n            <jats:p>Multivariable analysis showed R0 resection was the main factor associated with long-term survival. The 3-year overall-survival rate for R0 resection was 48% for endometrial malignancy, 40.6% for ovarian, 49.4% for cervical, 43.8% for vaginal, 59% for bladder, 48.3% for anal, and 48.1% for sarcoma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Pelvic exenteration remains an important treatment in selected patients with advanced or recurrent nonrectal pelvic malignancy. The range in 3-year overall survival following R0 resection (40%\u201359%) reflects the diversity of tumor types.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sla.0000000000003533","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T14:59:14Z","timestamp":1569423554000},"page":"899-905","source":"Crossref","is-referenced-by-count":102,"title":["Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy"],"prefix":"10.1097","volume":"270","member":"276","reference":[{"key":"R1-20230923","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1245\/ASO.2006.03.082","article-title":"Pelvic exenteration for advanced pelvic malignancies","volume":"13","author":"Pawlik","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R2-20230923","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/bjs.7373","article-title":"Multivisceral resection for primary locally advanced rectal carcinoma","volume":"98","author":"Harris","year":"2011","journal-title":"Br J surg"},{"key":"R3-20230923","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/DCR.0000000000000656","article-title":"Outcomes of pelvic exenteration with en bloc partial or complete pubic bone excision for locally advanced primary or recurrent pelvic cancer","volume":"59","author":"Austin","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"R4-20230923","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/DCR.0000000000000196","article-title":"Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies","volume":"57","author":"Milne","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"R5-20230923","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of the pelvic viscera for advanced carcinoma","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"R6-20230923","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/DCR.0000000000000421","article-title":"Outcomes after en bloc iliac vessel excision and reconstruction during pelvic exenteration","volume":"58","author":"Brown","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"R7-20230923","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/DCR.0b013e3181a73f48","article-title":"Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement","volume":"52","author":"Austin","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R8-20230923","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00384-016-2711-6","article-title":"Extended lymphadenectomy for locally advanced and recurrent rectal cancer","volume":"32","author":"Georgiou","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"R9-20230923","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1007\/s00268-009-0066-7","article-title":"Total pelvic exenteration for primary and recurrent malignancies","volume":"33","author":"Ferenschild","year":"2009","journal-title":"World J Surg"},{"key":"R10-20230923","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/bjs5.50153","article-title":"Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer","volume":"3","year":"2019","journal-title":"BJS Open"},{"key":"R11-20230923","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/DCR.0b013e31827a7868","article-title":"Pelvic exenteration for rectal cancer: a systematic review","volume":"56","author":"Yang","year":"2013","journal-title":"Dis Colon Rectum"},{"key":"R12-20230923","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/bjs.9192_1","article-title":"Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes","volume":"100","year":"2013","journal-title":"Br J Surg"},{"key":"R13-20230923","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0000000000002528","article-title":"Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an International collaboration","volume":"269","year":"2019","journal-title":"Ann Surg"},{"key":"R14-20230923","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/bjs.10734","article-title":"Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer","volume":"105","year":"2018","journal-title":"Br J Surg"},{"key":"R15-20230923","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0b013e31828a0d22","article-title":"Indications and outcomes of pelvic exenteration for locally advanced primary and recurrent rectal cancer","volume":"259","author":"Bhangu","year":"2014","journal-title":"Ann Surg"},{"key":"R16-20230923","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.3748\/wjg.v24.i45.5144","article-title":"Pelvic exenterations for primary rectal cancer: analysis from a 10-year national prospective database","volume":"24","author":"Pellino","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R17-20230923","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/DCR.0000000000000839","article-title":"Pelvic exenteration surgery: the evolution of radical surgical techniques for advanced and recurrent pelvic malignancy","volume":"60","author":"Brown","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"R18-20230923","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SLA.0000000000001963","article-title":"A systematic review to assess resection margin status after abdominoperineal excision and pelvic exenteration for rectal cancer","volume":"265","author":"Simillis","year":"2017","journal-title":"Ann Surg"},{"key":"R19-20230923","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/DCR.0000000000000679","article-title":"Palliative pelvic exenteration: clinical outcomes and quality of life","volume":"59","author":"Quyn","year":"2016","journal-title":"Dis Colon Rectum"},{"key":"R20-20230923","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s10350-006-0651-x","article-title":"Value of intraoperative radiotherapy in locally advanced rectal cancer","volume":"49","author":"Ferenschild","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"R21-20230923","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s10350-004-0891-6","article-title":"Preoperative radiotherapy improves outcome in recurrent rectal cancer","volume":"48","author":"Vermaas","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"R22-20230923","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/jjco\/hyg036","article-title":"Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer","volume":"33","author":"Ito","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"R23-20230923","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/DCR.0b013e3181e10b0e","article-title":"Clinical algorithms for the surgical management of locally recurrent rectal cancer","volume":"53","author":"Mirnezami","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"R24-20230923","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/IGC.0b013e318287a874","article-title":"Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution","volume":"23","author":"J\u00e4ger","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"R25-20230923","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.ejso.2016.05.006","article-title":"Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus","volume":"42","author":"Alamri","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R26-20230923","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00268-010-0637-7","article-title":"Pelvic exenteration for advanced and recurrent malignancy","volume":"34","author":"Zoucas","year":"2010","journal-title":"World J Surg"},{"key":"R27-20230923","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/bjs.8820","article-title":"Multivisceral resections for rectal cancer","volume":"99","author":"Smith","year":"2012","journal-title":"Br J Surg"},{"key":"R28-20230923","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1463-1318.2011.02893.x","article-title":"A 1-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database","volume":"14","author":"Nielsen","year":"2012","journal-title":"Colorectal Dis"},{"key":"R29-20230923","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ejso.2005.07.007","article-title":"Exenterative pelvic surgery eleven-year experience of the Swansea Pelvic Oncology Group","volume":"31","author":"Nguyen","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R30-20230923","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1072-7515(99)00229-X","article-title":"Total pelvic exenteration for locally advanced rectal cancer","volume":"190","author":"Law","year":"2000","journal-title":"J Am Coll Surg"},{"key":"R31-20230923","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000070385","article-title":"Curative surgery for local pelvic recurrence of rectal cancer","volume":"20","author":"Saito","year":"2003","journal-title":"Dig Surg"},{"key":"R32-20230923","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1245\/s10434-007-9385-9","article-title":"Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma","volume":"14","author":"Gannon","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R33-20230923","first-page":"CD010449","article-title":"Exenterative surgery for recurrent gynaecological malignancies","volume":"4","author":"Ang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R34-20230923","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/bjs.9392","article-title":"Quality of life and other patient-reported outcomes following exenteration for pelvic malignancy","volume":"101","author":"Young","year":"2014","journal-title":"Br J Surg"},{"key":"R35-20230923","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ejso.2016.01.007","article-title":"Systematic review of health-related quality of life in patients undergoing pelvic exenteration","volume":"42","author":"Harji","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"R36-20230923","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/codi.13647","article-title":"A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer","volume":"19","author":"Rausa","year":"2017","journal-title":"Colorectal Dis"},{"key":"R37-20230923","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejso.2016.02.016","article-title":"Outcomes of pelvic exenteration for locally advanced primary rectal primary rectal cancer: Overall survival and quality of life","volume":"42","author":"Quyn","year":"2016","journal-title":"Eur J Surg Oncol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T06:15:11Z","timestamp":1695449711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SLA.0000000000003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000003533","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}